The U.S. Food and Drug Administration (FDA) has accepted for review the Biologics License Application (BLA) for Sanofi’s MenQuadfi^TM Meningococcal Vaccine candidate to help prevent meningococcal meningitis (Groups A, C, Y, W)

We go to pre-natal scans, baby-proof our homes and teach our kids to swim, all in a bid to keep them safe.

At the height of the flu season, headlines often claim “next generation” or “new and improved” influenza vaccines.